I was away at copper Mt. on a ski trip, came back to this. Any comments?
Pharmos share added 4.7% up to 3.4 $, after dropping 22% in last two days. The Head of BOD and CEO of the company, Chaim Aviv, exercised at the beginning of the week part of the options pack he owns, and earned 380 thousands dollars. Exercising options is a common procedure in the market, but when it happens in a company like Pharmos, that is due to publish in month the results of the P3 of the Dexanabinol drug study, is not obvious at all. The move of Aviv, anyway, caused the decline of investor’s trust of study supposed success, although Pharmos explained that Aviv does not know the study results and he only exercised his options to reduce risks. |
